Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alzamend Neuro, Inc.

Clinical trials sponsored by Alzamend Neuro, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New crystallized lithium aims to improve bipolar treatment Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Could a custom vaccine slow Alzheimer's? new trial begins

Disease control Ongoing

This early-phase trial tests a personalized vaccine (ALZN002) made from a patient's own immune cells, designed to train the body to attack amyloid plaques in the brain. Thirty people with mild-to-moderate Alzheimer's will receive either the vaccine or a placebo. The main goal is …

Phase 1/2 • Sponsor: Alzamend Neuro, Inc. • Aim: Disease control

Last updated Jun 26, 2026 13:08 UTC